FDA Fast Track application is a very real possibil
Post# of 30025
http://www.fda.gov/ForPatients/Approvals/Fast/ucm405399.htm
JN clearly sees Eltroprazine as meeting an unmet need for PD patients. MJFF's support for Eltoprazine's development in the past makes continued support a good possibility. Looking very good indeed!